Leerink Partners Remains Bullish on DBV Technologies (DBVT) Following 1Q15 Results

Leerink Partners reiterates an Outperform rating and $44.00 price target on DBV Technologies S.A (NASDAQ: DBVT) following 1Q15 financial results.

Analyst Joseph Schwartz commented, "We are updating our model to reflect 1Q15 financial results. More importantly, we are encouraged by timely execution of midto-late stage development of Viaskin Peanut and Milk programs, the former of which remains on track to embark upon a global Ph.3 PEPITES trial in 4Q15. Reiterate OP and $44 PT."

For an analyst ratings summary and ratings history on DBV Technologies S.A click here. For more ratings news on DBV Technologies S.A click here.

Shares of DBV Technologies S.A closed at $29.78 yesterday.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Seacoast Banking Corporation of Florida (SBCF) Tops Q1 EPS by 2c
• Federated Hermes (FHI) Reports In-Line Q1 EPS